| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.28 | 0.4 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.2 | 0.001 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |